How did off‑label and veterinary use of ivermectin during the COVID‑19 pandemic affect reported adverse events and pharmacovigilance signals?
Off‑label and veterinary use of during the COVID‑19 pandemic produced a measurable uptick in reported adverse events and produced clearer “signals,” driven largely by misuse, overdosing and ingestion ...